Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Patel, Achchhe  [Clear All Filters]
2023
Iannello G, Patel A, Sirabella D, Diaz AGarcia, Hoover BN, Sarmah H, Corneo B. Simple, Fast, and Efficient Method for Derivation of Dermal Fibroblasts From Skin Biopsies. Curr Protoc. 2023;3(3):e714.
2022
Carcamo-Orive I, Hoffman GE, Cundiff P, Beckmann ND, D'Souza SL, Knowles JW, Patel A, Hendry C, Papatsenko D, Abbasi F, et al. Analysis of Transcriptional Variability in a Large Human iPSC Library Reveals Genetic and Non-genetic Determinants of Heterogeneity. Cell Stem Cell. 2022;29(10):1505.
Iannello G, Patel A, Sirabella D, Corneo B, Thaker V. Corrigendum to "Generation of the iPSC line CUIMCi003-A derived from a patient with severe early onset obesity" [Stem Cell Res 54 (2021) 102432]. Stem Cell Res. 2022;61:102778.
2021
Iannello G, Patel A, Sirabella D, Corneo B, Thaker V. Generation of the iPSC line CUIMCi003-A derived from a patient with severe early onset obesity. Stem Cell Res. 2021;54:102432.
2020
Patel A, Diaz AGarcia, Moore JC, Sirabella D, Corneo B. Establishment and characterization of two iPSC lines derived from healthy controls. Stem Cell Res. 2020;47:101926.
Garcia-Diaz A, Efe G, Kabra K, Patel A, Lowry ER, Shneider N, Corneo B, Wichterle H. Standardized reporter systems for purification and imaging of human pluripotent stem cell-derived motor neurons and other cholinergic cells. Neuroscience. 2020.
2019
Riera M, Patel A, Corcostegui B, Chang S, Sparrow JR, Pomares E, Corneo B. Establishment and characterization of an iPSC line (FRIMOi001-A) derived from a retinitis pigmentosa patient carrying PDE6A mutations. Stem Cell Res. 2019;35:101385.
Riera M, Patel A, Corcostegui B, Chang S, Corneo B, Sparrow JR, Pomares E. Generation of an induced pluripotent stem cell line (FRIMOi002-A) from a retinitis pigmentosa patient carrying compound heterozygous mutations in USH2A gene. Stem Cell Res. 2019;35:101386.
Riera M, Patel A, Burés-Jelstrup A, Corcostegui B, Chang S, Pomares E, Corneo B, Sparrow JR. Generation of two iPS cell lines (FRIMOi003-A and FRIMOi004-A) derived from Stargardt patients carrying ABCA4 compound heterozygous mutations. Stem Cell Res. 2019;36:101389.